Fig. 3From: Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancerEffectiveness of 131I-Atezolizumab RIT on RKO model and HCT8 model. a Design of therapy protocol. b, c Tumor volume. d, e Body weight change. f, g Survival curveBack to article page